No matter what stage of product development you’re working on, we have a solution for you.
Blog
Inflation Reduction Act of 2022: No Room for Negotiation
Long-awaited Medicare price negotiations look more like statuary discounts than the value-based negotiations seen in global healthcare systems; combined with expanded price increase rebates and out of pocket limits, new regulation may drive prices for new drugs up more than down. Trinity explores the impact and implications for manufacturers of innovative medicines.
Read More
Blog
Mapping the Unknown: Measuring Cell and Gene Therapy Adoption Using Real-World Evidence
August 9, 2022 It’s been 10 years since the first pediatric patient was treated with chimeric antigen receptor T-cell (CAR-T) therapy for her acute lymphoblastic leukemia. At the time, the approach to engineer immune cells was a novel, ground-breaking concept. In the subsequent decade, research into this space had continued to advance. Equally importantly, the […]
Read More
Blog
The Humira Case: Exploring the Blockbuster Ahead of United States Biosimilar Launch
Up to nine biosimilar versions of Humira (adalimumab) are expected to launch in 2023 in the United States, following settlements between AbbVie and their respective manufacturers. In contrast, biosimilar versions of adalimumab have been available in most countries […]
Read More
Director,
Head of Quantitative Insights
Clive designs and applies sound market research methodologies and analytics to generate meaningful insights of commercial importance to the industry. His research expertise spans all facets of commercial development and across many disease areas. Clive leads the research innovation team at Trinity with a continued focus on bringing academic rigor to our research projects and […]
Principal
Caroline has a decade of life sciences consulting experience with Trinity, partnering with life science clients to generate evidence-based insights that enable strategic decision making. Her specialty lies in partnering with companies focused on commercial assessments, BD/NPP strategy, pipeline/portfolio prioritization and strategy, bringing deep expertise in rare diseases, pulmonology and immunology. Caroline earned a healthcare […]
Senior Vice President, Commercial Operations Management Advisor
John works with commercial operations leaders within the top 35 pharmaceutical/biotech companies to optimize existing commercial operations departments. In addition, he has established new central departments in companies where none previously existed in pre-commercial to Top 10 firms. John’s 20+ years in the industry has positioned him to respond to the needs of pharmaceutical clients. […]
Senior Partner,
Insights
Aparna leads the design and execution of primary market research projects in support of Trinity’s consulting engagements. She specializes in shaping therapeutic area commercial strategy through insights and analytics across multiple disease areas. Aparna’s focus is on helping clients identify the “right” business questions, developing a hypothesis-based approach to address the question and leveraging her […]
Senior Vice President, Emerging Life Sciences Network
Curt has over 30 years of experience on both the consulting and client side. He currently leads the TGaS Emerging Life Sciences Network focused on supporting pre-commercial and emerging companies. Recently, Curt has created the TGaS Chief Commercial Officers Network which provides a forum for CCO’s to address common issues and challenges. During his time at […]
Partner
Amanda has been a key leader of Trinity’s strategic advisory group for a decade. Known for her expertise in new product planning, strategic business development and L&A work, Amanda also specializes in leading large, integrated projects that involve strategic advisory services, primary market research, and secondary data analytics. Over nearly a dozen years, she has […]
Principal &
Head of Patient Centricity
Jennifer currently leads Trinity’s Patient Centricity Center of Excellence, helping Trinity’s clients weave the Voice of the Patient into all facets of the product lifecycle. Jennifer’s group works closely with Trinity’s Strategic Advisory, PMR and RWE teams to produce deep patient insights based in real-world data, that are tactically actionable for a wide range of […]
